NZ600267A - Combined oral preparation of theobromine and a decongestant for cough therapy - Google Patents

Combined oral preparation of theobromine and a decongestant for cough therapy

Info

Publication number
NZ600267A
NZ600267A NZ600267A NZ60026710A NZ600267A NZ 600267 A NZ600267 A NZ 600267A NZ 600267 A NZ600267 A NZ 600267A NZ 60026710 A NZ60026710 A NZ 60026710A NZ 600267 A NZ600267 A NZ 600267A
Authority
NZ
New Zealand
Prior art keywords
theobromine
decongestant
antihistamine
oral preparation
combined oral
Prior art date
Application number
NZ600267A
Other languages
English (en)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Priority claimed from PCT/GB2010/052085 external-priority patent/WO2011073646A1/en
Publication of NZ600267A publication Critical patent/NZ600267A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NZ600267A 2009-12-14 2010-12-14 Combined oral preparation of theobromine and a decongestant for cough therapy NZ600267A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052085 WO2011073646A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough

Publications (1)

Publication Number Publication Date
NZ600267A true NZ600267A (en) 2013-07-26

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ600267A NZ600267A (en) 2009-12-14 2010-12-14 Combined oral preparation of theobromine and a decongestant for cough therapy

Country Status (17)

Country Link
EP (1) EP2512472A1 (xx)
JP (2) JP2013513652A (xx)
CN (1) CN102802625A (xx)
AU (1) AU2010332495C1 (xx)
BR (1) BR112012014159A8 (xx)
CA (1) CA2784215A1 (xx)
CO (1) CO6541638A2 (xx)
GB (1) GB0921803D0 (xx)
IL (1) IL220384A0 (xx)
MX (1) MX2012006624A (xx)
NZ (1) NZ600267A (xx)
PE (1) PE20121538A1 (xx)
RU (1) RU2012129675A (xx)
SG (2) SG181603A1 (xx)
UA (1) UA105827C2 (xx)
WO (1) WO2011073647A1 (xx)
ZA (1) ZA201204294B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
CN103263533B (zh) * 2013-05-31 2014-11-05 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104224819B (zh) * 2014-09-18 2016-08-17 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247709B1 (en) * 1986-04-17 1991-01-02 Alza Corporation Chlorpheniramine therapy
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
JPH10316568A (ja) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003012514A (ja) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
BRPI0810893A2 (pt) * 2007-04-11 2014-10-29 Alcon Res Ltd Uso de inibidor de tnf-alfa a um anti-histamínico para tratar rinite alérgica e conjuntivite, e composição farmacêutica compreendendo os referidos compostos.

Also Published As

Publication number Publication date
RU2012129675A (ru) 2014-01-27
MX2012006624A (es) 2012-10-05
AU2010332495C1 (en) 2016-02-11
ZA201204294B (en) 2013-02-27
EP2512472A1 (en) 2012-10-24
CN102802625A (zh) 2012-11-28
JP6078605B2 (ja) 2017-02-08
BR112012014159A2 (pt) 2017-08-29
GB0921803D0 (en) 2010-01-27
IL220384A0 (en) 2012-08-30
CO6541638A2 (es) 2012-10-16
WO2011073647A1 (en) 2011-06-23
AU2010332495B2 (en) 2015-01-22
PE20121538A1 (es) 2012-12-21
UA105827C2 (uk) 2014-06-25
JP2016040280A (ja) 2016-03-24
BR112012014159A8 (pt) 2017-12-26
JP2013513652A (ja) 2013-04-22
AU2010332495A1 (en) 2012-06-21
SG181603A1 (en) 2012-07-30
CA2784215A1 (en) 2011-06-23
SG10201408374WA (en) 2015-01-29

Similar Documents

Publication Publication Date Title
NZ600267A (en) Combined oral preparation of theobromine and a decongestant for cough therapy
ZA202303227B (en) Crystalline forms of a bruton's tyrosine kinase inhibitor
US8097625B2 (en) Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
NZ702485A (en) The use of inhibitors of bruton’s tyrosine kinase (btk)
HUE045784T2 (hu) Eliglusztát (Genz 112638) mint glükozilceramid-szintáz inhibitor Fabry- vagy Gaucher-kór kezelési eljárásában történõ alkalmazásra, az eljárás tartalmazza az egyedi terápiás dózisnak a beteg P-450 metabolizmusához történõ beállítását
IL218165A (en) Stable Pharmaceutical Formulations Highly Concentrated to Provide Subcutaneous Active Pharmaceutical Antibody against CD20
IL244945A0 (en) Cationic lipid, lipid formulations including it and their use in the preparation of therapeutic agents for administration to cells
JP2013513652A5 (xx)
ES2525497T3 (es) Composiciones farmacéuticas de liberación controlada que comprenden un éster de ácido fumárico
TW200602022A (en) Use of PDE III inhibitor for the reduction of heart size in mammals suffering from heart failure
IL212586A (en) Derivative 3 - (1, 3-benzoxazole-5-yl) pyrzolo [3, 4-d] pyrimidine-4-amine, a pharmaceutical preparation and the use of a drug derivative
UA104136C2 (ru) Фармацевтическая композиция, которая включает ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, и способ ее получения
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
EP1587925A4 (en) METHOD OF SUPPLEMENTING SIRNA TO HEART MUSCLE TISSUE
UA110463C2 (ru) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 4-{[9-ХЛОР-7-(2-ФТОР-6-МЕТОКСИФЕНІЛ)-5Н-ПІРИМІДО[5,4-d][2]БЕНЗАЗЕПІН-2-ІЛ]АМІНО}-2-МЕТОКСИБЕНЗОЙНОЇ КИСЛОТИ ДЛЯ ЛІКУВАННЯ РАКУ Й ІНШИХ ЗАХВОРЮВАНЬ І ПОРУШЕНЬ СТАНУ ЗДОРОВ'Я
FR2909867B3 (fr) Capsule remplie d'un medicament, en particulier d'un medicament inhalable.
MX2009010165A (es) Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
EP1644043A1 (en) Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
NZ595376A (en) Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
IL246247A0 (en) Use of an anti-human prolactin receptor in the preparation of a drug to inhibit the growth of cancer
WO2011047837A3 (de) Schmelzgranuliertes cinacalcet
SI2379066T1 (sl) Uporaba opioidnih antagonistov za pripravo zdravila za zdravljenje degenerativnih bolezni retine
PL2050435T3 (pl) Preparat przeciwkaszlowy
UA105944C2 (uk) Комбінація теоброміну з деконгестантом і її застосування для лікування кашлю
NZ595798A (en) Ectoparasiticidal methods and formulations

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE UNKNOWN(124) HAS BEEN CORRECTED TO 25/05/2012

Effective date: 20130718

ERR Error or correction

Free format text: THE UNKNOWN(124) HAS BEEN CORRECTED TO 28/05/2012

Effective date: 20130911

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2015 BY OLCOTT

Effective date: 20141012

ASS Change of ownership

Owner name: INFIRST HEALTHCARE LIMITED, GB

Effective date: 20141106

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2016 BY OLCOTT

Effective date: 20151128

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2017 BY OLCOTT INTERANTIONAL

Effective date: 20161205

LAPS Patent lapsed